Search

Author/Creator Basoglu, Tugba

1. How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature. (June 2020)

Authors:
Alan, Ozkan; Kuzhan, Okan; Koca, Sinan; Telli, Tugba Akin; Basoglu, Tugba; Ercelep, Ozlem; Filinte, Deniz; Sengul, Yildiz; Arikan, Huseyin; Kaya, Serap; Babacan, Nalan Akgul; Dane, Faysal; Yumuk, Perran Fulden
Journal:
Journal of oncology pharmacy practice
Issue:
Volume 26:Number 4(2020)
Page Start:
1011
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Issue 1 (February 2022)

Authors:
Cil, Ibrahim; Kucukarda, Ahmet; Atcı, Muhammed Mustafa; Secmeler, Saban; Paksoy, Nail; Ferhatoglu, Ferhat; Ak, Naziye; Ayhan, Murat; Tataroglu Ozyukseler, Deniz; Onder, Arif Hakan; Avci, Okan; Oyman, Abdilkerim; Okten, Ilker Nihat; Gulturk, Ilkay; Akagunduz, Baran; Basoglu, Tugba; Cakir, Emre; Ha...
Journal:
Tumori
Issue:
Volume 108:Issue 1(2022)
Page Start:
19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters. (May 2023)

Authors:
Arikan, Rukiye; Ozguven, Salih; Telli, Tugba Akin; Isik, Selver; Demircan, Nazım Can; Basoglu, Tugba; Yasar, Alper; Celebi, Abdussamet; Filizoglu, Nuh; Ustun, Hilal Sagiroglu; Tinay, Ilker; Ones, Tunc; Turoglu, Halil Turgut; Erdil, Tanju Yusuf; Ozturk, Mehmet Akif; Ercelep, Ozlem; Bayoglu, Vedat;...
Journal:
Acta radiologica
Issue:
Volume 64:Number 5(2023)
Page Start:
2040
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗